The US Department of Health and Human Services is investigating Janet Woodcock, the director of the FDA's Center for Drug Evaluation and Research, for conflict-of-interest during a drug approval. In addition, Daniel Schultz, head of the FDA's device regulation division, has resigned from the agency.
Wall Street Journal
Wall Street Journal
Wednesday 12 August 2009
Problems at FDA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment